Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
Psoriasis is a chronic inflammatory disease that primarily affects the skin, and its complications include a predisposition to atherosclerosis and cardiovascular disease (CVD), with this risk related to the severity of psoriasis. The mechanisms by which psoriasis predisposes to CVD are not clear. Th...
Saved in:
Main Author: | Andrés Tirado-Sánchez |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2025-01-01
|
Series: | Revista Médica del Hospital General de México |
Subjects: | |
Online Access: | https://www.hospitalgeneral.mx/frame_eng.php?id=242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Profile of proinflammatory markers in pregnant women who died of severe COVID-19
by: Pablo B. Bautista-García, et al.
Published: (2025-01-01) -
Cardiovascular Drug Therapy /
by: Messerli, Franz H.
Published: (1990) -
Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01) -
PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psoriasis
by: Anella Saviano, et al.
Published: (2025-03-01)